NFG
NVET

Next Financial Group’s Nexvet Biopharma plc Ordinary Shares NVET Stock Holding History

Next Financial Group’s Portfolio NVET Stock Details NVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-200
Closed – – 1920
2016
Q1 		$0 Sell
200
-1,100
-85% -$3.59K ﹤0.01% 1948
2015
Q4 		$4K Buy
1,300
+200
+18% +$790 ﹤0.01% 1485
2015
Q3 		$4K Buy
1,100
+300
+38% +$1.37K ﹤0.01% 1518
2015
Q2 		$3K Buy
+800
New +$5.54K ﹤0.01% 1639

Other funds holding NVET

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
LLC
Latimer Light Capital New York $432M AUM 25.5% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Next Financial Group's NVET Position: Q2 2016 in Review

Next Financial Group sold out of Nexvet Biopharma plc Ordinary Shares (NVET) in Q2 2016, closing a stake of 200 shares.

Next Financial Group first reported a position in NVET in Q2 2015 and held it in 4 quarters. The position peaked at $4K in Q4 2015. 15 funds tracked by Wall St. Rank hold NVET as of Q2 2016.

  • Next Financial Group reported no remaining Nexvet Biopharma plc Ordinary Shares position as of Q2 2016 after selling out during the quarter.
  • Next Financial Group sold 200 Nexvet Biopharma plc Ordinary Shares shares in Q2 2016.
  • Next Financial Group first reported a position in Nexvet Biopharma plc Ordinary Shares in Q2 2015 and held it in 4 quarters.
  • Next Financial Group's Nexvet Biopharma plc Ordinary Shares position peaked at $4K in Q4 2015.
  • 15 funds tracked by Wall St. Rank held Nexvet Biopharma plc Ordinary Shares as of Q2 2016.

Based on Next Financial Group's 13F filing for Q2 2016, filed 7 Jul 2016.